featured
DESTINY-Breast04 Updated Results: Trastuzumab Deruxtecan in HER2-Low Unresectable and/or Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: